Human Parathyroid Hormone (2-34)

An N-terminally truncated human PTH fragment with reduced agonist potency relative to PTH (1-34), useful for defining the contribution of the first residue.

PTH1 receptor pharmacology, bone-signaling studies, ligand internalization research and structure-activity experiments.

This sequence-defined peptide is intended for research use. Confirm solubility, storage, concentration and assay controls for the intended experimental system. The supplied material is not intended for diagnostic or therapeutic use.